Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
GLYC | GLYCOMIMETICS INC | King Rachel K. | Director | Dec 29, 2023 | Option Exercise | $2.36 | 4,238 | 10,002 | 511,860 | Jan 02, 2024, 04:05 PM | |
NVAX | NOVAVAX INC | King Rachel K. | Director | May 19, 2021 | Buy | $139.64 | 700 | 97,748 | 2,800 | May 21, 2021, 05:06 PM | |
GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Dec 28, 2020 | Sale | $2.21 | 214,997 | 475,648 | 440,240 | Dec 30, 2020, 04:00 PM | |
GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Aug 06, 2019 | Option Exercise | $1.12 | 166,759 | 186,770 | 307,144 | Aug 07, 2019, 04:29 PM | |
NVAX | NOVAVAX INC | King Rachel K. | Director | Mar 27, 2019 | Buy | $0.53 | 42,000 | 22,252 | 42,000 | Mar 28, 2019, 04:21 PM | |
NVAX | NOVAVAX INC | King Rachel K. | Director | Mar 27, 2019 | Buy | $0.53 | 44,000 | 23,311 | 22,000 | Mar 28, 2019, 04:21 PM | |
GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Feb 24, 2015 | Option Exercise | $1.12 | 50,000 | 56,000 | 167,206 | Feb 26, 2015, 05:02 PM | |
GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Jun 18, 2014 | Option Exercise | $1.12 | 100,000 | 112,000 | 108,706 | Jun 20, 2014, 04:00 PM |